Download PDF
Thromb Haemost 2003; 90(01): 158-159
DOI: 10.1055/s-0037-1613614
Letters to the Editor
Schattauer GmbH

Haemolytic anaemia secondary to trimethoprim/sulfamethoxazole use

Bahri Ermis
,
Ibrahim Caner
,
Mehmet Karacan
,
Hasim Olgun
Further Information

Publication History

Received 04 February 2003

Accepted after revision 19 March 2003

Publication Date:
07 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Sackey K. Hemolytic anemia. Pediatr Rev 1999; 20 (05) 152-9.
    CrossrefPubMedGoogle Scholar
  • 2 Gehrs BC, Friedberg RC. Autoimmune he-molytic anemia. Am J Hematol 2002; 69: 258-71.
    CrossrefPubMedGoogle Scholar
  • 3 Domen R. An overview of immune hemolytic anemias. Cleve Clin J Med 1998; 65: 89-99.
    CrossrefPubMedGoogle Scholar
  • 4 Reinke CM, Thomas JK, Graves AH. Apparent hemolysis in an AIDS patient receiving trimethoprim/sulfamethoxazole: case report and literature review. J Pharm Technol 1996; 11 (06) 256-62.
    PubMedGoogle Scholar
  • 5 Calabro V, Cascone A, Malaspina P. et al. Glucose-6-phosphate dehydrogenase (G6PD) deficiency in southern Italy: a case of G6PD A(-) associated with favism. Haematologica 1989; 74 (01) 71-3.
    PubMedGoogle Scholar
  • 6 Taraszewski R, Harvey R, Rosman P. Death from drug-induced hemolytic anemia. Post-grad Med 1989; 85 (07) 79-80.
    PubMedGoogle Scholar